Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Asks Philippines High Court To Reconsider Imports Decision

This article was originally published in PharmAsia News

Executive Summary

GlaxoSmithKline Philippines asked the Philippines Supreme Court to reconsider a decision that had the effect of declaring there is no law safeguarding the country from imported drugs not registered with the government. GSK wants a new look at a recent Supreme Court ruling that the Universally Accessible Cheaper and Quality Medicines Act of 2008 allows anyone to import and use medicines without fear of being prosecuted under the Counterfeit Drugs Act, which it declared void. GSK Philippines said the court in effect nullified the Bureau of Food and Drugs as well as the counterfeit law, so it filed a motion for the court to reconsider the decision. GSK said it had a different reading of the Cheaper Medicines Act, one that says the safeguards are in place. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071883

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel